This common pill may stop cancer dead in its tracks

This common pill may stop cancer dead in its tracks

~!!~Laboratory tests indicate that a molecule called prostaglandin E2 (PGE2) is produced by skin, breast, and bowel cancer cells// Aspirin, according to the study, appears to stop the production of this molecule, allowing the immune system to battle against the tumors//© 

~!!~Tests on mice revealed that aspirin made immunotherapy more effective against malignant cancer// Prof// Caetano Reisa Sousa of the Francis Crick Institute in London, who led the team, said that the key to stopping cancer may be blocking PGE2, and aspirin may be an effective tool int hat regard, according to the report//© 

~!!~PGE2 may also explain why experimental immunotherapy treatments have been disappointing// PGE2 appears to be the key, as it tells the immune system to ignore cancer cells//©